
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of cbdMD (AMEX:YCBD) through any online brokerage.
Other companies in cbdMD’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
cbdMD has a consensus price target of $2.00.
The stock price for cbdMD (AMEX: YCBD) is $ last updated .
There are no upcoming dividends for cbdMD.
cbdMD does not have any upcoming earnings scheduled.
There is no upcoming split for cbdMD.
cbdMD is in the Health Care sector and Pharmaceuticals industry. They are listed on the AMEX.